Interview: Jurgi Camblong – CEO, Sophia Genetics, Switzerland

Jurgi Camblong, Cofounder and CEO, Sophia GeneticsAs Artificial Intelligence and Next Generation Sequencing started to converge, Sophia Genetics was created to bring the world towards an era of real-time epidemiology. CEO Jurgi Camblong discusses the company’s worldwide impact thus far, and the next steps towards making Data-Driven Medicine a reality for patients around the world. What transformation in medicine led to the creation of Sophia Genetics?
"Sophia Genetics has developed SOPHiA, an artificial intelligence which is connecting hospitals and experts, and analyzing the genomic data they produce."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report